Company Profile

Glycosensors and Diagnostics LLC
Profile last edited on: 4/13/2018      CAGE: 4XHN3      UEI: JTGCK219C6F4

Business Identifier: Commercializing glycoscience technologies
Year Founded
2007
First Award
2009
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

111 Riverbend Road
Athens, GA 30602
   (706) 549-4484
   glycosensors@gmail.com
   www.glycosensors.com
Location: Multiple
Congr. District: 10
County: Clarke

Public Profile

Headquartered in Georgia, with a satellite in San Diego, Glycosensors & Diagnostics (G&D) is a biotechnology company, spun-out from the research group at the Complex Carbohydrate Research Center, that is developing technologies for applications in glycoscience. The firm is pioneering the use of advanced computational simulations to guide the development of carbohydrate-related technologies: custom engineered glycan-binding proteins called Lectenz, the GlycoSense platform for glycoprofiling of glycoproteins, and the GlycoPlex platform for determining the affinity and specificity of glycan-binding proteins. G&D customers include biopharma, contract manufacturing organizations, and research institutions.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 2 NIH $1,743,284
Project Title: Pan-Specific Tools and Reagents for the Enrichment of Sialo-Glycans
2021 2 NIH $450,000
Project Title: Development of a suite of high-specificity fucose binding reagents
2021 2 NIH $447,791
Project Title: Novel Reagents for Monitoring Sulfation Patterns in Heparin and Heparan Sulfate
2020 2 NIH $1,748,064
Project Title: High-Specificity Affinity Reagents for the Detection of Glycan Sialylation
2018 2 NIH $449,888
Project Title: Reagents Specific for All N-Glycans

Key People / Management

  Robert J Woods -- President

  Kausar Samli -- Chief Executive Officer

  Shengcheng Wu

  Loretta Yang -- Chief Scientific Officer

Company News

There are no news available.